Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics • Medical Devices & Mechanical Engineering
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
UNIVERSITY OF HAWAII has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being handled by 1 distinct examiner, VANHORN, ABIGAIL LOUISE. This examiner is the busiest for the company, with 1 pending office action. The portfolio's current activity is restricted to 1 distinct art unit, which indicates a specific technical focus for the university's pending application.
Because there is only 1 pending office action, the prosecution strategy is entirely dependent on the 1 distinct examiner. Practitioners should analyze the specific tendencies of VANHORN, ABIGAIL LOUISE within the 1 distinct art unit to navigate the 1 pending office action effectively. The data shows a streamlined path for the university's current intellectual property efforts. With 1 pending office action and 1 distinct examiner, the practitioner can focus exclusively on the requirements of the 1 distinct art unit. The role of VANHORN, ABIGAIL LOUISE is central as they manage the only 1 pending office action currently in the portfolio.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 1 (20%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MESSERSMITH, ERIC J | 1 | 69.4% | +25.0% |
| TCHERKASSKAYA, OLGA V | 1 | 55.5% | +46.4% |
| MORGAN, BAILEY MICHELLE | 1 | 56.3% | +58.3% |
| GILL, RACHEL B | 1 | 65.4% | +28.8% |
| TON, TRI T | 1 | 86.1% | +10.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18017752 | Antibody/Adjuvant Compositions and Methods of Immune Response Generation against Coronaviruses | GILL, RACHEL B | 125d overdue |
| 17720687 | METHODS OF PARTICLE MANIPULATION AND ANALYSIS | TON, TRI T | 70d overdue |
| 18268032 | BURKHOLDERIA VACCINES AND THERAPEUTICS | MORGAN, BAILEY MICHELLE | 14d |
| 18513938 | BIOINSECTICIDAL COMPOSITIONS CONTAINING MONOTERPENES AND METHODS OF USE THEREOF | TCHERKASSKAYA, OLGA V | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18017752 | Antibody/Adjuvant Compositions and Methods of Immune Response Generation against Coronaviruses | GILL, RACHEL B | 125d overdue |
| 17720687 | METHODS OF PARTICLE MANIPULATION AND ANALYSIS | TON, TRI T | 70d overdue |
| 18268032 | BURKHOLDERIA VACCINES AND THERAPEUTICS | MORGAN, BAILEY MICHELLE | 14d |
| 18711190 | BIOIMPEDANCE MEASUREMENT DEVICE AND METHOD | MESSERSMITH, ERIC J | — |
| 18513938 | BIOINSECTICIDAL COMPOSITIONS CONTAINING MONOTERPENES AND METHODS OF USE THEREOF | TCHERKASSKAYA, OLGA V | — |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| 1615 | 1 |
| 1645 | 1 |
| 1671 | 1 |
| 2877 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18711190 | BIOIMPEDANCE MEASUREMENT DEVICE AND METHOD | MESSERSMITH, ERIC J | 3791 | §103 | Non-Final OA | — | Pending | May 17, 2024 |
| 18513938 | BIOINSECTICIDAL COMPOSITIONS CONTAINING MONOTERPENES AND METHODS OF USE THEREOF | TCHERKASSKAYA, OLGA V | 1615 | §102§103§112 | Non-Final OA | — | Pending | Nov 20, 2023 |
| 18268032 | BURKHOLDERIA VACCINES AND THERAPEUTICS | MORGAN, BAILEY MICHELLE | 1645 | §101§102 | Final Rejection | 14d | Pending | Jun 16, 2023 |
| 18017752 | Antibody/Adjuvant Compositions and Methods of Immune Response Generation against Coronaviruses | GILL, RACHEL B | 1671 | §102§103§112 | Non-Final OA | 125d overdue | Pending | Jan 24, 2023 |
| 17720687 | METHODS OF PARTICLE MANIPULATION AND ANALYSIS | TON, TRI T | 2877 | §103§112 | Non-Final OA | 70d overdue | Pending | Apr 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Hawai'i has 5 pending office actions as of October 2026, spread across 5 art units and 5 examiners.
Eric J Messersmith has the most, with 1 of University of Hawai'i's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
